BeiGene denies AbbVie's accusation of "stealing trade secrets": will launch a firm defense and development projects will not be interrupted as a result
楚一帆
发表于 昨天 21:29
119
0
0
On September 12th, the A-share price of BeiGene (SH688235, stock price 144.01 yuan, market value 198.44 billion yuan) fell sharply by 10.61%.
On the afternoon of the 12th, BeiGene told the Daily Economic News reporter that the company has recently learned that AbbVie has filed a lawsuit against the company, claiming that BeiGene has stolen its trade secrets for the Bruton's tyrosine kinase (BTK) degradation agent project, which includes the compound BGB-16673 independently discovered by BeiGene researchers through years of innovative research.
According to BeiGene's 2024 interim report, BGB-16673 is an investigational chimeric degradation activating compound (CDAC) targeting BTK. On August 27th, BeiGene announced that the FDA has granted the drug fast track status for the treatment of adult patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have previously received at least two lines of treatment, including BTK inhibitors and BCL2 inhibitors.
In addition, the company also expects in its 2024 interim report that the first trial of BGB-16673 for the treatment of R/R and CLL/SLL will enroll the first subject in the fourth quarter of 2024 or the first quarter of 2025.
BeiGene told reporters that the company will vigorously defend itself against the allegations made by AbbVie. The company denies this accusation and will firmly defend its intellectual property rights against the lawsuit. BeiGene believes that the lawsuit intends to hinder the development process of BGB-16673, which is currently the fastest progressing BTK degradation agent in clinical development. BeiGene had already applied for a patent for BGB-16673 several years before AbbVie first applied for a BTK degradation agent patent. BeiGene firmly believes that its research and development projects adhere to the principle of integrity.
BeiGene's focus on advancing the BGB-16673 development project will not be interrupted by this lawsuit. We are currently carefully reviewing AbbVie's complaint and will respond appropriately through legal procedures. In addition, this lawsuit will not affect our ability to serve patients or carry out operations, "BeiGene said.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- After a series of twists and turns, the core product of Baekje Shenzhou, Baekze An, has become the second domestically produced PD-1 approved in the United States
- BeiGene: Net profit for 2023 is approximately -6.716 billion yuan
- BeiGene: Chief Financial Officer Wang Aijun will resign on July 19th
- Beike responds to land acquisition in Xi'an: a 1+2 model for diversified cooperation and non independent development projects
- Company Review | BeiGene has suffered continuous losses in the past 7 years, and its stock price is under pressure. Can the new CFO bring a turning point?
- More than 40% reduction in losses in the first half of the year, but multiple peers have achieved profits. BeiGene is facing increasing peer pressure
- AbbVie sues for infringement again, BeiGene denies allegations: this move is intended to prevent project development
- Domestic innovative drug leader faces another 'patent challenge': AbbVie accuses BTK degradation agent of infringement, causing BeiGene's stock price to suffer a setback
- BeiGene responds to AbbVie's lawsuit alleging theft of trade secrets: with the intention of obstructing the development process
-
外汇市场的投资者们眼下正面临着一段艰难的时期,因为美元的走势可能将变得愈发难以预测。在本周美国总统大选辩论和关键的美国CPI数据发布之后,市场参与者预计到年底前汇市的波动性将会进一步攀升。 汇市交 ...
- jhy3810
- 昨天 00:38
- 支持
- 反对
- 回复
- 收藏
-
热门中概股涨跌不一,纳斯达克中国金龙指数涨0.06%,本周累计上涨1.03%。蔚来涨超5%。
- sicklyman
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
新京报讯(记者王萍)9月24日,新京报记者获悉,百胜中国与保利发展控股在广州保利发展广场签署战略合作协议,将进一步加速百胜中国在社区商业方面的拓展步伐。 据悉,双方将充分利用各自在商业领域的技术 ...
- sicklyman
- 昨天 13:08
- 支持
- 反对
- 回复
- 收藏
-
新华财经北京9月13日电(记者李唐宁)在9月12日开幕的2024年中国国际服务贸易交易会“数字贸易发展趋势和前沿论坛”上,百度集团副总裁、深度学习技术及应用国家工程研究中心副主任吴甜表示,人工智能大模型具备 ...
- llyyy2008
- 3 天前
- 支持
- 反对
- 回复
- 收藏